SCHEMBL9903565

SCHEMBL9903565

Cc1cccc(CN(CCN)Cc2cccc(C)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.58
IDO1 P14902 2/20 0.47
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RECQL P46063 1/20 0.43
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
PRMT8 Q9NR22 1/20 0.43
ACHE P22303 1/20 0.39
SLC1A5 Q15758 1/20 0.39
CALM1 P0DP23 1/20 0.39
CAMKK2 Q96RR4 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900482 0.84 CARM1 (0.65) TAAR1IDO1CYP2D6CYP2C9CYP2C19
SCHEMBL4916691 0.83 TAAR1 (0.45) TAAR1IDO1CYP2D6CYP2C9CYP2C19
SCHEMBL4916817 0.81 TAAR1 (0.43) TAAR1IDO1CYP2D6ALDH1A1
SCHEMBL4917408 0.81 TAAR1 (0.43) TAAR1IDO1CYP2D6ALDH1A1
SCHEMBL8625800 0.80 TAAR1 (0.36) TAAR1CARM1PRMT6PRMT8ALDH1A1
SCHEMBL18271856 0.80 TAAR1 (0.51) TAAR1IDO1CYP2D6CYP2C9CYP2C19
SCHEMBL13775217 0.79 HRH3 (0.52) TAAR1IDO1CYP2D6CYP2C9CYP2C19
SCHEMBL25962067 0.79 TSHR (0.51) CYP2D6CYP2C9CYP2C19RECQLCALM1
Hydrochloric Acid SCHEMBL8537155 0.79 TAAR1 (0.35) TAAR1CARM1PRMT6PRMT8ALDH1A1
SCHEMBL12772089 0.79 TAS2R14 (0.50) TAAR1IDO1CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462141-B1 NOVEL AZAHETEROCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2017-09-27 EP disclosed
US-9023847-B2 Azaheterocyclic compounds MERCK PATENT GMBH (DE) 2015-05-05 US disclosed
CN-101168601-B Crosslinkers for improving stability of polyurethane foams AIR PROD & CHEM 2013-03-06 CN disclosed
US-20120277228-A1 Novel Azaheterocyclic Compounds MERCK PATENT GMBH (DE) 2012-11-01 US disclosed
EP-2462141-A1 NOVEL AZAHETEROCYCLIC COMPOUNDS Merck Patent GmbH (DE) 2012-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277228-A1 Novel Azaheterocyclic Compounds PCNA, MCL1, MYC TAAR1 3741/4885IDO1 4057/4885CYP2D6 2277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.